Israel Discount Bank of New York Lowers Position in Zimmer Biomet Holdings, Inc. (ZBH)

Israel Discount Bank of New York cut its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 1.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,798 shares of the medical equipment provider’s stock after selling 105 shares during the quarter. Israel Discount Bank of New York’s holdings in Zimmer Biomet Holdings were worth $744,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Bronfman E.L. Rothschild L.P. lifted its stake in Zimmer Biomet Holdings by 25.3% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after acquiring an additional 167 shares during the period. Parkside Financial Bank & Trust lifted its position in shares of Zimmer Biomet Holdings by 2.7% during the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 22 shares during the last quarter. Parallel Advisors LLC lifted its position in shares of Zimmer Biomet Holdings by 20.8% during the first quarter. Parallel Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock valued at $138,000 after buying an additional 199 shares during the last quarter. IHT Wealth Management LLC lifted its position in shares of Zimmer Biomet Holdings by 28.4% during the first quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock valued at $139,000 after buying an additional 256 shares during the last quarter. Finally, Sandy Spring Bank lifted its position in shares of Zimmer Biomet Holdings by 1.7% during the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after buying an additional 20 shares during the last quarter. 85.48% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Israel Discount Bank of New York Lowers Position in Zimmer Biomet Holdings, Inc. (ZBH)” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://sportsperspectives.com/2017/09/10/israel-discount-bank-of-new-york-lowers-position-in-zimmer-biomet-holdings-inc-zbh.html.

Several research firms have commented on ZBH. Stifel Nicolaus reissued a “hold” rating and set a $125.00 price target on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Gabelli began coverage on shares of Zimmer Biomet Holdings in a research report on Thursday, August 24th. They set a “buy” rating and a $142.00 price target for the company. Zacks Investment Research lowered shares of Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 8th. BMO Capital Markets reissued a “buy” rating and set a $136.00 price target on shares of Zimmer Biomet Holdings in a research report on Tuesday, July 11th. Finally, Wells Fargo & Company reissued a “market weight” rating on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Zimmer Biomet Holdings has an average rating of “Hold” and a consensus price target of $136.75.

Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) traded up 0.03% during trading on Friday, reaching $115.70. 999,596 shares of the company traded hands. Zimmer Biomet Holdings, Inc. has a 1-year low of $95.63 and a 1-year high of $133.49. The stock’s 50 day moving average is $116.64 and its 200 day moving average is $120.78. The company has a market capitalization of $23.39 billion, a price-to-earnings ratio of 32.95 and a beta of 1.21.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.10 by $0.02. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. Zimmer Biomet Holdings’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.02 EPS. On average, analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.83%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s payout ratio is 27.59%.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Sang Yi sold 17,731 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $124.56, for a total value of $2,208,573.36. The disclosure for this sale can be found here. 1.07% of the stock is owned by insiders.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply